Merck has expressed interest in buying more than $ 3 billion in Swiss Moonlake

American Pharmaceutical Company Merck & Co. The Swiss biotechnology company, Moonlake Immunotherapeutics, was negotiating on the purchase of $ 3 billion, according to informed sources of Financial Times. Merck made a similar offer for the company's purchase early this year. The offer was rejected, however, the sources ...